| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | MTMR12-like_C | 3.97e-06 | 3 | 22 | 2 | IPR022587 | |
| Domain | 3-PAP | 3.97e-06 | 3 | 22 | 2 | PF12578 | |
| Domain | PPASE_MYOTUBULARIN | 1.20e-04 | 14 | 22 | 2 | PS51339 | |
| Domain | Myotubularin_fam | 1.20e-04 | 14 | 22 | 2 | IPR030564 | |
| Domain | Myotub-related | 1.20e-04 | 14 | 22 | 2 | PF06602 | |
| Domain | Myotubularin-like_Pase_dom | 1.20e-04 | 14 | 22 | 2 | IPR010569 | |
| Domain | C2 | 5.37e-04 | 137 | 22 | 3 | SM00239 | |
| Domain | - | 6.72e-04 | 148 | 22 | 3 | 2.60.40.150 | |
| Domain | C2_dom | 9.05e-04 | 164 | 22 | 3 | IPR000008 | |
| Domain | Prot-tyrosine_phosphatase-like | 6.00e-03 | 99 | 22 | 2 | IPR029021 | |
| Domain | Helicase_C | 6.97e-03 | 107 | 22 | 2 | PF00271 | |
| Domain | HELICc | 6.97e-03 | 107 | 22 | 2 | SM00490 | |
| Domain | Helicase_C | 7.10e-03 | 108 | 22 | 2 | IPR001650 | |
| Domain | HELICASE_CTER | 7.22e-03 | 109 | 22 | 2 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 7.22e-03 | 109 | 22 | 2 | PS51192 | |
| Domain | DEXDc | 7.22e-03 | 109 | 22 | 2 | SM00487 | |
| Domain | Helicase_ATP-bd | 7.35e-03 | 110 | 22 | 2 | IPR014001 | |
| Domain | C2 | 1.03e-02 | 131 | 22 | 2 | PF00168 | |
| Domain | C2 | 1.20e-02 | 142 | 22 | 2 | PS50004 | |
| Pathway | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_EARLY_ENDOSOME_MEMBRANE | 5.41e-07 | 16 | 15 | 3 | M639 | |
| Pathway | WP_PHOSPHOINOSITIDES_METABOLISM | 1.74e-05 | 49 | 15 | 3 | M40046 | |
| Pathway | REACTOME_PI_METABOLISM | 8.82e-05 | 84 | 15 | 3 | M676 | |
| Pathway | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_EARLY_ENDOSOME_MEMBRANE | 1.10e-04 | 15 | 15 | 2 | MM14643 | |
| Pubmed | The E3 ubiquitin ligase UBR5 regulates centriolar satellite stability and primary cilia. | 3.82e-07 | 2 | 22 | 2 | 29742019 | |
| Pubmed | PTEN and myotubularin phosphatases: from 3-phosphoinositide dephosphorylation to disease. | 3.82e-06 | 5 | 22 | 2 | 12495846 | |
| Pubmed | 5.72e-06 | 6 | 22 | 2 | 32876667 | ||
| Pubmed | 2.51e-05 | 12 | 22 | 2 | 16787938 | ||
| Pubmed | 7.96e-05 | 21 | 22 | 2 | 9446795 | ||
| Pubmed | 8.76e-05 | 22 | 22 | 2 | 11154208 | ||
| Pubmed | Signalling crosstalk in FGF2-mediated protection of endothelial cells from HIV-gp120. | 1.14e-04 | 25 | 22 | 2 | 15689238 | |
| Pubmed | Targeting the glycans of glycoproteins: a novel paradigm for antiviral therapy. | 1.14e-04 | 25 | 22 | 2 | 17632570 | |
| Pubmed | 1.57e-04 | 167 | 22 | 3 | 25659891 | ||
| Pubmed | 5.17e-04 | 251 | 22 | 3 | 29778605 | ||
| Pubmed | 5.56e-04 | 55 | 22 | 2 | 31985874 | ||
| Pubmed | 6.18e-04 | 58 | 22 | 2 | 31067491 | ||
| Pubmed | 6.31e-04 | 638 | 22 | 4 | 31182584 | ||
| GeneFamily | Myotubularins|Phosphoinositide phosphatases | 7.66e-05 | 15 | 16 | 2 | 903 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-E|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.99e-05 | 136 | 22 | 3 | edfd453c9a650d69d05a5a3ab15f7df56349fa86 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-E-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.99e-05 | 136 | 22 | 3 | 03e4e2353c23ceffde35b2d0aadd15299e3db09f | |
| ToppCell | tumor_Lung-Myeloid_cells-Pleural_Mac|Myeloid_cells / Location, Cell class and cell subclass | 4.93e-05 | 146 | 22 | 3 | 8b2d104fdb0fdb09410450c6c651e1edb00cae44 | |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.74e-05 | 170 | 22 | 3 | ba4ba66b624089ed50a9083176386c7941b4c7a3 | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.47e-05 | 182 | 22 | 3 | a20017b6a4f9a6a29e090e4dbd7c02ed1495bd50 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type. | 9.94e-05 | 185 | 22 | 3 | 857c7ca8493e91ef1d0078ddafd6082020f9b169 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.04e-04 | 188 | 22 | 3 | fe7143c36e4a883745862d3c3147cf751b440e46 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.04e-04 | 188 | 22 | 3 | cbf32b675a7cd0c808d5c9c22dfa7fa79fbe2437 | |
| ToppCell | COPD-Endothelial-VE_Capillary_A|Endothelial / Disease state, Lineage and Cell class | 1.04e-04 | 188 | 22 | 3 | 1aa0e35b1c28ac847886fece16c3ef7fc6fcdd51 | |
| ToppCell | LAM-Endothelial-VasEndo-1|LAM / Condition, Lineage and Cell class | 1.06e-04 | 189 | 22 | 3 | 454e64b1ee93edebbc1576fbf7c3a6db332fa927 | |
| ToppCell | COPD-Myeloid-ncMonocyte|World / Disease state, Lineage and Cell class | 1.08e-04 | 190 | 22 | 3 | aece860b5609ad5a8fc920d685f0d0ec71bf9018 | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.09e-04 | 191 | 22 | 3 | f229abf69a1217194f74b0502486907e07dba989 | |
| ToppCell | IPF-Endothelial-VE_Capillary_A|Endothelial / Disease state, Lineage and Cell class | 1.14e-04 | 194 | 22 | 3 | 777ce41c3f22c591e2d81120f189b834e53ffb4b | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_aerocyte_capillary-EC_aerocyte_capillary_L.2.0.1.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.18e-04 | 196 | 22 | 3 | a53caedd0103bd162b3aee8ab87b4442a5e0338f | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 1.20e-04 | 197 | 22 | 3 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 1.20e-04 | 197 | 22 | 3 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.22e-04 | 198 | 22 | 3 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.22e-04 | 198 | 22 | 3 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | Goblet_3|World / shred by cell class for nasal brushing | 1.23e-04 | 199 | 22 | 3 | 4229a17a3a6d8855655acc0a1c8704166f8e74c0 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.25e-04 | 200 | 22 | 3 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | COVID-19-COVID-19_Mild|COVID-19 / Disease, condition lineage and cell class | 1.25e-04 | 200 | 22 | 3 | 62c25042086f1afd1102e0720e933c2e476468fd | |
| ToppCell | severe-NK_CD56bright|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.25e-04 | 200 | 22 | 3 | 82818ab1796fdd0b8be02b341818897595eed841 | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 4.74e-03 | 145 | 21 | 2 | DOID:1289 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SKNGKNQMVIAFFHP | 56 | Q2TAA5 | |
| KTPFQSFLGMAQQHS | 296 | Q6ZTN6 | |
| NMQHPGSRKFNTTER | 13651 | Q8WXI7 | |
| GTFLFNSPHQRVKQS | 501 | Q9NXD2 | |
| TFFFNSPHQKDTNMG | 491 | Q9C0I1 | |
| MNHTVQTFFSPVNSG | 1 | Q01628 | |
| QVGSQRFSVNMPHKF | 231 | Q02156 | |
| HMQTQSSPFARGNVF | 741 | Q1MSJ5 | |
| ILPFTSMRHQGTQKS | 366 | O95447 | |
| RYNSHQMGQSKQFPL | 651 | Q6PIJ6 | |
| SKNFMNVSGPHRVNV | 196 | Q3L8U1 | |
| MNHTVQTFFSPVNSG | 1 | C9JQL5 | |
| PLNFTGGQLHSRMFQ | 161 | Q92820 | |
| SQFKRGFMQGHVNRQ | 416 | Q9H2U1 | |
| FSQPSSQTAFHMQVR | 206 | Q9NQT6 | |
| KHSQMREFGAPQFSN | 311 | Q8NDH6 | |
| QHQTRIKMGNNPFFN | 196 | A0AVI2 | |
| MANRGKHTNGSQFFI | 111 | P30414 | |
| STKHGFMQFIQSVPV | 676 | Q8NEB9 | |
| QSFHQMRSKQFPVSG | 351 | Q71H61 | |
| ISHVGQPMLNFSFNS | 456 | Q8WY91 | |
| TGQNHPFFRRSDSMT | 2016 | O95071 | |
| IMPNSSVHNNGKSFI | 441 | Q9C0D4 |